68Ga-Ga-NOTA-RG2

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug Name68Ga-Ga-NOTA-RG2
Drug Alias Name68Ga-Ga-NOTA-RG268Ga-NOTA-RG2
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionPositron-emission tomography enhancersGlypican-3 modulators
TargetsGlypican-3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesHuashan Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHuashan Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A